| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55c0fd222c2115ff2fcd6d2ee30a2874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35dbc60da9891d57c4047fb7b8689516 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate |
2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdf925b3c03abf203bfdba00e631751d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d798d5b328a16f14ca0ac218fe28da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_639a93394a4102be9d6d58d4930ea0b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58216e8c1179790200c16cc9372aede4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b5130dd8e8cf8d23f00b303a7a97b7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a913f0df1f2b58adc275be81e69e7bc9 |
| publicationDate |
2021-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113573742-A |
| titleOfInvention |
Novel tumor antigen binding agent and use thereof |
| abstract |
The present invention provides compounds according to general formula (1)(i) or (1)(ii): wherein A is a diagnostic or therapeutic agent comprising a binding site for a tumor antigen and the spacer comprises at least one C-N bond . |
| priorityDate |
2018-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |